Siemens AG to acquire US-based Dotmatics for $5.1 billion
HQ Team April 3, 2025: Siemens AG will acquire US, Boston-based Dotmatics for $5.1 billion from Insight Partners to expand its digital life.
Drugs
Health
Pharma
Drugs
Health
Pharma
Bavarian Nordic gets FDA nod for free-dried smallpox, mpox vaccine
HQ Team April 2, 2025: Denmark’s Bavarian Nordic A/S has got approval from the US Food and Drug Administration for its freeze-dried formulation.
Drugs
Medical
Pharma
Organon & Co. buys biosimilar from Biogen for an undisclosed sum
HQ Team April 2, 2025: Organon has acquired the commercial rights for a biosimilar for intravenous infusion in treating arthritis and Covid-19 from.
Drugs
Health
Pharma
AstraZeneca’s mantle cell cancer drug gets body’s nod for EU approval
HQ Team April 1, 2025: AstraZeneca’s drug to treat adult patients with previously untreated mantle cell lymphoma has been recommended for European Union.
Drugs
Medical
Pharma
GSK’s drug to fight urinary tract infections gets USFDA approval
HQ Team March 26, 2025: The US Food and Drug Administration has approved Britain’s GSK Plc’s drug to treat urinary tract infections in.
Health
Medical
Pharma
WHO unveils new guidelines to tackle mental health systems, policies
HQ Team March 26, 2025: The World Health Organization has issued new guidelines to help reform and strengthen mental health policies and systems.
Drugs
Health
Pharma
Merck signs $2b licensing deal with Jiangsu Hengrui for heart disease drug
HQ Team March 25, 2025: Merck & Co., Inc. has bought global rights for an experimental oral drug to treat heart diseases from.
Drugs
Medical
Pharma
Novo Nordisk in $2b deal with Chinese firm for ‘triple-G’ obesity drug
HQ Team February 25, 2025: Novo Nordisk has inked a $2 billion licensing pact with United Laboratories International for the development, manufacturing and.
Drugs
Health
Pharma
Funding cuts ‘severely’ bleeding UN’s child survival, stillbirth programs
HQ Team March 25, 2025: Progress in slowing child mortality and stillbirth deaths has received a severe blow due to global funding cuts.
Drugs
Pharma
Brazil’s pharma giant Hypera to launch generic Ozempic in 2026
Bharti Jayshankar March 24, 2025: Brazilian pharmaceutical giant Hypera announced plans to introduce a generic version of semaglutide—the active ingredient in Novo Nordisk’s.